bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Viridian Therapeutics Inc. logo

    Viridian Therapeutics Inc.

    VRDN | NASDAQ
    Chart Builder DCF Calculator
    $21.60
    -$0.40 (-1.82%)
    At close: Sep 21, 2026, 4:00 PM ET
    $21.50
    -$0.10 (-0.46%)
    Pre-market: Sep 22, 2026, 8:39 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $2.44B
    Enterprise Value
    $1.71B
    Beta
    0.96
    Average Volume
    2.22M
    Shares Outstanding (Diluted)
    107.88M
    Shares Change YoY
    32.22%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US92790C1045

    Price Performance

    Price Change 1M
    -11.3%
    Price Change 3M
    25.0%
    Price Change 6M
    -23.8%
    Price Change YTD
    -29.6%
    Price Change 1Y
    10.5%
    Price Change 3Y
    39.0%
    Price Change 5Y
    35.3%
    1M CAGR (ann.)
    -8.5%
    1Y CAGR (ann.)
    10.0%
    5Y CAGR (ann.)
    11.7%
    All-Time CAGR
    -31.0%

    Valuation

    PE Ratio
    -6.12
    Forward PE
    N/A
    PEG Ratio
    -0.68
    Forward PEG
    0.18
    PS Ratio
    34.40
    Forward PS
    10.60
    PB Ratio
    3.70
    P/FCF Ratio
    -5.38
    P/Adj. FCF Ratio
    -4.69
    P/OCF Ratio
    -6.99
    EV/Sales
    24.01
    EV/EBIT
    -4.64
    EV/EBITDA
    -4.64
    EV/FCF
    -3.76
    Earnings Yield
    -16.3%
    FCF Yield
    -18.6%
    Adj. FCF Yield
    -21.3%

    Financial Health

    Net Cash
    $739.37M
    Total Debt
    $242.16M
    Cash & Short-Term Investments
    $981.53M
    Total Assets
    $1.1B
    Current Ratio
    16.95
    Quick Ratio
    16.95
    Debt / Equity Ratio
    0.37
    Debt / EBITDA
    -0.66
    Debt / FCF
    -0.53
    OCF / Debt
    -1.87
    Interest Coverage
    -21.40
    Altman Z-Score
    1.44
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    99.5%
    Operating Profit Margin
    -569.7%
    EBITDA Margin
    -517.4%
    Net Profit Margin
    -544.1%
    FCF Margin
    -639.3%
    Adj. FCF Margin
    -733.5%
    SBC / Revenue
    75.4%
    SBC Impact (per share)
    -14.7%

    Returns

    Return on Assets
    -35.3%
    Return on Equity
    -61.4%
    Return on Invested Capital
    -39.2%
    Return on Capital Employed
    -39.2%
    Return on Tangible Assets
    -35.6%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    264.4%
    Revenue CAGR 5Y
    93.9%
    Revenue CAGR 10Y
    37.9%
    EPS CAGR 3Y
    9.1%
    EPS CAGR 5Y
    12.1%
    EPS CAGR 10Y
    18.9%
    FCF CAGR 3Y
    -46.0%
    FCF CAGR 5Y
    -39.5%
    FCF CAGR 10Y
    -32.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    16
    EPS Growth Next 3Y
    45.9%
    Revenue Growth Next 3Y
    130.8%
    Earnings Date
    Nov 3, 2026
    EPS Estimate (next Q)
    -$0.99
    EPS Growth Est (next Q)
    190.8%
    Revenue Est (next Q)
    $4.03M
    Revenue Growth Est (next Q)
    -94.3%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $36.14
    Price Target Upside
    67.3%

    Cash Flow

    Operating Cash Flow
    $-453M
    Free Cash Flow
    $-454.72M
    Adj. Free Cash Flow
    $-521.72M
    FCF Per Share
    -$3.11
    OCF Per Share
    -$3.09
    OCF/S Ratio
    -468.7%

    Income Statement

    Revenue
    $71.13M
    Gross Profit
    $70.69M
    Operating Income
    $-405.2M
    EBITDA
    $-368.03M
    Net Income
    $-386.97M
    EPS (Diluted)
    -$3.53
    Revenue / Employee
    $282.25K
    Profit / Employee
    $-1.54M
    Employees
    252

    © 2026 bestshares.com. All rights reserved.